Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment

Author： Berns E.M.J.J.   Foekens J.A.   van Staveren I.L.   van Putten W.L.J.   de Koning H.Y.W.C.M.   Portengen H.   Klijn J.G.M.  

Publisher： Elsevier

ISSN： 0378-1119

Source： Gene, Vol.159, Iss.1, 1995-06, pp. : 11-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer

By Vogt U.   Bielawski K.   Schlotter C.M.   Bosse U.   Falkiewicz B.   Podhajska A.J.  

Gene, Vol. 223, Iss. 1, 1998-11 ,pp. : 375-380

Elsevier

Access to resources Recommend Favorite

Gene diagnostics provide new insights into breast cancer prognosis and therapy

By Benz C.C.   Brandt B.H.   Zanker K.S.  

Gene, Vol. 159, Iss. 1, 1995-06 ,pp. : 3-7

Elsevier

Access to resources Recommend Favorite

A new hypothesis on the role of c-erbB2 oncogene in the progress of breast cancer

By Petrov S.   Raskin G.   Khasanov R.  

Bulletin of Experimental Biology and Medicine, Vol. 142, Iss. 1, 2006-07 ,pp. : 94-97

Springer Publishing Company

Access to resources Recommend Favorite

Reversibility of oncogene-induced cancer

By Felsher D.W.  

Current Opinion in Genetics & Development, Vol. 14, Iss. 1, 2004-02 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Systemic Taxotere Chemotherapy for Metastatic Tumor Pleurisy in Cats with Spontaneous Breast Cancer

By Yakunina M.   Treshalina E.  

Bulletin of Experimental Biology and Medicine, Vol. 150, Iss. 5, 2011-03 ,pp. : 642-644

Springer Publishing Company

Access to resources Recommend Favorite